PUBLIC COMPANY
saveBRIM Biotechnology Inc
updated 2mo ago
community read0 votes
pipeline
2
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 21Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- —BRM421 Ophthalmic Solution in Patients With Limbal Stem Cell Deficiency
- phase2A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease
- phase2Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis
- phase3Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects.
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that